ANIXA BIOSCIENCES, INC. Gain (Loss) on Sale of Properties
ANIXA BIOSCIENCES, INC. (ANIX) reported Gain (Loss) on Sale of Properties of $5.00 thousand for the 12-month period ending 2021-10-31, per its 10-K filed 2022-01-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:GainLossOnSaleOfProperties · last filed 2022-01-04
- ANIXA BIOSCIENCES, INC. gain (loss) on sale of properties for fiscal 2021 was $5.00K.
| Period end | Gain (Loss) on Sale of Properties 12 month |
|---|---|
| 2021-10-31 | $5.00K 10-K · filed 2022-01-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |